Table of ContentsTen Years After: Where is ISAP?“Objects and Purposes of the Society” “Objects and Purposes of the Society” “Objects and Purposes of the Society” FDA Moderization Act (1997) FDAMA Developing Antimicrobial Drugs General Considerations (7/98) PK/PD Parameters with Beta-Lactams PK/PD Parameters with Fluoroquinolones PK/PD Parameters and Levofloxacin PK/PD Parameters with Fluoroquinolones Pharmacodynamics and Regulatory Organizations Factors to Consider when Establishing Breakpoints (NCCLS)-M23 Document |
Author: William A. Craig
Email: webmaster@isap.org Home Page: http://www.isap.org/slides.htm Important Note: These slides are for information only. Do not make public use of them without autorization of the author and of the ISAP Webmaster |